SEARCH

SEARCH BY CITATION

References

  • 1
    American Cancer Society. Cancer facts & figures 2007. Atlanta: American Cancer Society, 2007.
  • 2
    Blot WJ,Devesa SS,Kneller RW,Fraumeni JF,Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 12879.
  • 3
    Devesa SS,Blot WJ,Fraumeni JF,Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 204953.
  • 4
    Blot WJ,Devesa SS,Fraumeni JF,Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993; 270: 1320.
  • 5
    Blot WJ,McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999; 26: 28.
  • 6
    El-Serag HB,Mason AC,Petersen N,Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002; 50: 36872.
  • 7
    Brown LM,Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 23556.
  • 8
    Younes M,Henson DE,Ertan A,Miller CC. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 2002; 37: 135965.
  • 9
    Kubo A,Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004; 99: 5828.
    Direct Link:
  • 10
    Wu X,Chen VW,Ruiz B,Andrews P,Su LJ,Correa P. Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: subsite and histology differences. Cancer 2006; 106: 68392.
  • 11
    Wu X,Chen VW,Andrews PA,Ruiz B,Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control 2007; 18: 58593.
  • 12
    Kubo A,Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002; 95: 2096102.
  • 13
    Daly JM,Karnell LH,Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996; 78: 18208.
  • 14
    Chow WH,Blot WJ,Vaughan TL,Risch HA,Gammon MD,Stanford JL,Dubrow R,Schoenberg JB,Mayne ST,Farrow DC,Ahsan H,West AB, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 1505.
  • 15
    Farrow DC,Vaughan TL,Sweeney C,Gammon MD,Chow WH,Risch HA,Stanford JL,Hansten PD,Mayne ST,Schoenberg JB,Rotterdam H,Ahsan H, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000; 11: 2318.
  • 16
    El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007; 5: 1726.
  • 17
    Flegal KM,Carroll MD,Ogden CL,Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 17237.
  • 18
    Wingo PA,Jamison PM,Hiatt RA,Weir HK,Gargiullo PM,Hutton M,Lee NC,Hall HI. Building the infrastructure for nationwide cancer surveillance and control—a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance. Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 2003; 14: 17593.
  • 19
    Bosetti C,Levi F,Ferlay J,Garavello W,Lucchini F,Bertuccio P,Negri E,La Vecchia C. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 2008; 122: 111829.
  • 20
    Hankey BF,Ries LA,Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999; 8: 111721.
  • 21
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2002 Incidence and Mortality Web-based Report Version. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, 2005.Available at: www.cdc.gov/cancer/npcr/uscs/. Accessed January 8, 2007.
  • 22
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999 Incidence. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2002.
  • 23
    World Health Organization. International classification of diseases for oncology, 3rd edn. Geneva, Switzerland: World Health Organization, 2000.
  • 24
    World Health Organization. International classification of diseases for oncology, 2nd edn. Geneva, Switzerland: World Health Organization, 1990.
  • 25
    National Cancer Institute. Conversion programs, ICD-O-2 to 3 and ICD-O-3 to 2 Surveillance, Epidemiology, and End Results (SEER) Program, 2004. Bethesda, MD: National Cancer Institute, 2007.
  • 26
    Young JL,Roffers S,Ries L,Fritz A,Hurlbut AA. SEER Summary staging manual 2000. Bethesda, MD: National Cancer Institute, 2000.
  • 27
    Shambaugh EM,Weiss MA,Axtell LM. Summary staging guide for the cancer surveillance, epidemiology, and end results reporting (SEER) program. US Department of Health and Human Services: Washington, DC, 1977.
  • 28
    Howe HL,Jamison M,Havener L,Chen VW,Ries L. Site-specific comparison of summary stage 1977 and summary stage 2000 coding. [Internet] 2007 [cited 2007 January 8]; Available from: http://www.naaccr.org/index.asp?Col_SectionKey=11&Col_ContentID=397.
  • 29
    Havener L,Hulstrom D. Standards for cancer registries, Volume II:Data standards and data dictionary, 10th ed., Version 11ed. Springfield, IL: North American Association of Central Cancer Registries, 2004.
  • 30
    Espey DK,Wu XC,Swan J,Wiggins C,Jim MA,Ward E,Wingo PA,Howe HL,Ries LA,Miller BA,Jemal A,Ahmed F, et al. Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007; 110: 211952.
  • 31
    NAACCR Latino Research Work Group. NAACCR Guideline for Enhancing Hispanic/Latino Identification: Revised NAACCR Hispanic/Latino Identification Algorithm [NHIA v2]. Springfield, IL: North American Association of Central Cancer Registries, 2005.
  • 32
    Howe HL,Wu X,Ries LA,Cokkinides V,Ahmed F,Jemal A,Miller B,Williams M,Ward E,Wingo PA,Ramirez A,Edwards BK. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006; 107: 171142.
  • 33
    Howe HL. Evaluation of NHIA submissions for 1997–2001. Springfield, IL: North American Association of Central Cancer Registries, 2005.
  • 34
    Ellison JH,Wu XC,McLaughlin CC,Lake A,Firth R,Cormier M,Leonfellner S,Carozza S,Roney D,Howe H,Kosary C. Cancer in North America, 1999–2003. vol. 3:NAACCR Combined Incidence. Springfield, IL: North American Association of Central Cancer Registries, 2006.
  • 35
    Surveillance Research Program, National Cancer Institute, SEER*Stat software version 6.2.4. Available at: www.seer.cancer.gov/seerstat.
  • 36
    Alberts SR,Kelly JJ,Lanier AP,Sacco F. Occurrence of esophageal and gastric cancer in Alaska Natives, 1969–2003. Alaska Med 2006; 48: 211.
  • 37
    Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2005 Sub (1973–2003)-Linked To County Attributes-Total U.S., 1969–2003 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission.
  • 38
    Gammon MD,Schoenberg JB,Ahsan H,Risch HA,Vaughan TL,Chow WH,Rotterdam H,West AB,Dubrow R,Stanford JL,Mayne ST,Farrow DC, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89: 127784.
  • 39
    Engel LS,Chow WH,Vaughan TL,Gammon MD,Risch HA,Stanford JL,Schoenberg JB,Mayne ST,Dubrow R,Rotterdam H,West AB,Blaser M, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 140413.
  • 40
    National Center for Health Statistics. Health, United States, 2004 With Chartbook on Trends in the Health of Americansed. Hyattsville, MD: National Center for Health Statistics, 2004.
  • 41
    Recommendations regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 2001; 20: 1015.
  • 42
    Katz DL,O'Connell M,Yeh MC,Nawaz H,Njike V,Anderson LM,Cory S,Dietz W. Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005; 54: 112.
  • 43
    Rosenberg HM,Maurer JD,Sorlie PD,Johnson NJ,MacDorman MF,Hoyert DL,Spitler JF,Scott C. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. Vital Health Stat 2 1999: 113.
  • 44
    Clegg LX,Reichman ME,Hankey BF,Miller BA,Lin YD,Johnson NJ,Schwartz SM,Bernstein L,Chen VW,Goodman MT,Gomez SL,Graff JJ, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007; 18: 17787.
  • 45
    Thoburn KK,German RR,Lewis M,Nichols PJ,Ahmed F,Jackson-Thompson J. Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer 2007; 109: 160716.